Thanks, Pete. I’ll now walk through the key drivers behind our consolidated Q1 performance and then touch on segment level results. As Pete noted, we had a strong start to fiscal ‘25 with continued momentum in our Aerospace segment and solid execution across the organization. Gross margin expansion, improved EBITDA and strong operating cash flow are clear signs that the operational and financial initiatives we implemented over the past year are delivering results. Beginning in Q1 of fiscal ‘25, we implemented a change in how research and development expenses are presented in our financial statements. R&D is now shown as a separate line item below gross profit on the income statement, whereas previously, it was included within cost of goods sold. The prior period was recasted for comparability. This change enhances transparency and better aligns with common industry practices. That said, gross profit increased 28% year-over-year to $60.8 million, and gross margin expanded almost 390 basis points to 29.5%, up from 25.7% in the prior year quarter. This improvement reflects continued volume growth and favorable operating leverage in Aerospace. The quarter also included a $1.9 million adjustment, as Pete mentioned, in our Test segment related to the long-term contract. Operating income was $13.1 million for the quarter and includes a $6.2 million true-up to the reserve for the U.K. litigation matter, comprised of $0.5 million in additional damages and $5.7 million in interest-related accruals. We also incurred $3 million in legal expenses tied to the ongoing litigation. Excluding these items, adjusted operating income was $22.6 million or 11% of sales compared with $5.5 million and 3% in the prior year. Adjusted EBITDA was $30.7 million or 14.9% of sales, up from 9.5% last year, primarily reflecting improved profitability from the higher volume. Interest expense declined $2.6 million year-over-year due to our successful refinancing of the prior term loan and the ABL late last year. As we’ve discussed previously, the convertible bond financing was precautionary given the situation at the time with the potential outcome we could have realized with the U.K. damages award. Given the damages landing at just $12.5 million and interest expense of $5.7 million, we’re comfortable with our available liquidity. There’s still the issue of legal fee reimbursement that has not yet been settled on. The plaintiff is estimating $7.2 million. And given we believe we have valid grounds to dispute the position, we have not reserved for this amount. The lower interest rate on our convertible debt provides meaningful savings in addition to the liquidity cushion and will significantly reduce full year interest expense. GAAP earnings per share was $0.26. Non-GAAP adjusted EPS for the quarter was $0.44, a substantial increase from $0.05 in the prior year period. Turning to our segment level results; our Aerospace segment delivered record first quarter sales of $191.4 million, a 17% increase year-over-year. Commercial transport sales rose 13%, driven by continued strength in cabin power and in-flight entertainment and connectivity products. Military sales nearly doubled, up 95%, primarily due to our work on the FLRAA program and increased demand for lighting and safety products. Operating profit in Aerospace improved $10.2 million over the prior year. Adjusted segment operating profit was $31 million in the quarter compared with $15.6 million a year ago. And on an adjusted basis, Aerospace achieved 56% operating leverage on the higher volume. Adjusted operating margin improved by 660 basis points year-over-year to 16.2%. Turning to the Test segment; sales were $14.6 million, down $6.9 million from Q1 of last year. We recorded an adjusted operating loss of $1.5 million, which reflects a $1.9 million adjustment stemming from those revised cost estimates to the long-term mass transit contract. The updated estimates lowered the percentage of work completed, which in turn reduced revenue recognized for the period. This project is now anticipated to be completed later in 2026. The Test segment remains on track to achieve the $4 million to $5 million in annual cost savings with benefits expected to be more visible in the second half of the year. Bookings totaled $12 million in the quarter, driven by contributions across multiple product categories. While the second quarter will continue to be weak for this business, we continue to expect improvement in segment performance as the year progresses, underpinned by the next planned order under the radio test program for the Marines as well as the start of production for the U.S. Army radio test program, which we still anticipate in Q4. Now turning to cash flow and the balance sheet; we generated $20.6 million in operating cash flow, up sharply from $2 million in Q1 of last year. This improvement was driven by stronger cash earnings and more efficient working capital management. This also marks our second consecutive quarter with operating cash flow in excess of $20 million. I should point out that we have a number of items that will impact cash from operations in the second quarter, including the damages award and the interest payment on the U.K. case. There is also the potential that the legal fee reimbursement issue associated with that case could get determined and if not in our favor, paid in the second quarter. The second quarter cash from operations will also be impacted by significant income tax payments on the order of approximately $10 million related to ‘24 and ‘25. As our liquidity has improved, we have returned to making quarterly estimated payments. Long-term debt net of cash at the quarter end was $134.2 million, a $16 million reduction from the prior quarter. We finished the quarter with $25.9 million in cash and approximately $168 million of availability under our ABL facility. The ABL availability was reduced by the reserve for the damages and interest amounts due under the U.K. litigation. All said we ended the quarter with about $194 million in total liquidity. We’re currently undrawn on our revolver and expect that cash from operations can fund the business in the near-term. Our healthy balance sheet provides flexibility to consider value-creating initiatives, including acquisitions and share repurchases. We can continue to advance on our financing structure as well. As profitability continues to improve, we will evaluate a transition to a cash flow-based revolver, which is less restrictive and eliminates the liquidity block, all of which positions us well to settle the bonds in cash when the time comes. Capital expenditures in the quarter were $2.1 million. For the full year, we now expect CapEx to be in the range of $35 million to $50 million. This elevated level reflects both a catch-up on previously deferred investments and new spending tied to facility consolidation, capacity expansion and automation and efficiency efforts to support our long-term growth. The estimates on the facility build-out have come in higher than originally anticipated based on more detailed design specifications and current material costs. The team continues to get that amount down as much as possible. Overall, we’re pleased with the strong start to the year and encouraged by the underlying performance trends in our core Aerospace business. We remain focused on margin expansion, free cash flow generation and consistently executing on continuous improvement. And with that, let me turn it back to Pete.